Health Canada11 Aug 2026
Semaglutide Injection: Incorrect Pen in Package
Health Canada published a recall notice for Semaglutide Injection: Incorrect Pen in Package on 11 Aug 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 11 Aug 2026
- Recall type
- Health product recall
- Companies
- Recalling FirmDr. Reddy's Laboratories Canada Inc. 5580 Explorer Dr, Suite 204 Mississauga,ON L4W 4Y1Market Authorization HolderDR REDDY'S LABORATORIES LTDSurvey Nos. 42, 45, 46 & 54, Innovation Plaza, BachupallyMedchal-MalkajgiriTelanganaIndia 500090
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The affected lot contains a 4 mg pen but is labelled as a 2 mg pen. What you should do What to do: Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Dr. Reddy's Laboratories Canada Inc. Semaglutide Injection (labelled as 2mg/pen) DIN 02567806 Solution 1.34 mg/ml 7000544C Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.